Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment

Platelets
Waleed GhanimaJames B Bussel

Abstract

Bone marrow (BM) fibrosis is a potential side effect of thrombopoietin receptor agonist (TPO-RA) treatment. We aimed to investigate stromal seromarker profiles and growth factors in order to elucidate pathogenic and dynamic aspects of immune thrombocytopenia (ITP)-related BM fibrosis before and during TPO-RA treatment. Connective tissue metabolites [procollagen I and III peptides (PINP/PIIINP); hyaluronan (HYA), C-terminal-telopeptide (ICTP), and fibrosis-related growth factors (transforming growth factor-beta (TGF-beta), HGF, basic fibroblast growth factor)] were measured in blood samples acquired before initiation of TPO-RA and subsequently at 6-month intervals for up to 2 years. BM fibrosis was graded MF-0 in 8 (18%), MF-1 30 (65%), and MF-2 8 (18%) in the last available BM biopsy. In the 21 patients having more than one biopsy, the grade of fibrosis from the first to the last available biopsy decreased in 2 (10%), remained unchanged in 15 (71%), and increased in 4 (19%). Pretreatment levels of PIIINP, PINP, ICTP, and HYA were significantly increased in ITP versus controls. PINP, PIIINP, and HYA decreased on TPO-RA; ICTP remained unchanged. PINP:ICTP was lower before and during treatment compared to controls. Pretreatment, T...Continue Reading

References

Jan 1, 1991·American Journal of Hematology·H HasselbalchA Engström Laurent
Nov 1, 1985·Scandinavian Journal of Haematology·H HasselbalchK D Bentsen
Jul 1, 1971·American Journal of Clinical Pathology·D E Bauermeister
Mar 1, 1995·Clinical and Laboratory Haematology·J T ReillyA Smith
Oct 24, 2002·Blood·Hédia ChagraouiFrançoise Wendling
May 8, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P GarneroJ M Delaissé
Oct 20, 2006·The New England Journal of Medicine·James B BusselJanet L Nichol
Jan 30, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·Takashi KosoneMasatomo Mori
Oct 4, 2007·British Journal of Haematology·David J KuterRobert P Hasserjian
Nov 30, 2007·The New England Journal of Medicine·James B BusselJulian M Jenkins
May 27, 2009·World Journal of Gastroenterology : WJG·Axel-M GressnerOlav-A Gressner
Jul 14, 2010·Seminars in Hematology·David J Kuter
Jul 14, 2010·Seminars in Hematology·Waleed Ghanima, James B Bussel
Nov 12, 2010·The New England Journal of Medicine·David J KuterDietmar P Berger
Aug 16, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Leonardo BoiocchiJulia Turbiner Geyer
Sep 10, 2011·British Journal of Haematology·Waleed GhanimaJames B Bussel
Jul 7, 2012·Blood·Nikolaos PapadantonakisKatya Ravid
Jul 14, 2012·Thrombosis Research·Shinya FujitaShosaku Nomura
May 3, 2013·The Journal of Clinical Investigation·Detlef Schuppan, Yong Ook Kim
Mar 22, 2014·Frontiers in Immunology·Aaron C Petrey, Carol A de la Motte
Jan 21, 2016·British Journal of Haematology·Kay R TingPeter O'Gorman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.